We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase III Trial of Anaplastic Glioma Without 1p/19q LOH (CATNON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00626990
Recruitment Status : Active, not recruiting
First Posted : February 29, 2008
Last Update Posted : July 27, 2017
NCIC Clinical Trials Group
Radiation Therapy Oncology Group
Medical Research Council
Cooperative Trials Group for Neuro-Oncology
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC